SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Ethris and German Center for Infection Research (DZIF) Announce Strategic Collaboration to Develop mRNA-Based Vaccines
February 9, 2026
 · 
4 min read
Press Releases
Helsinn and ESTEVE expand their partnership extending the Distribution and Licence Agreement for AKYNZEO® and ALOXI® to Austria
February 9, 2026
 · 
4 min read
Press Releases
Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium
February 9, 2026
 · 
5 min read
Press Releases
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening
February 9, 2026
 · 
7 min read
Press Releases
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
February 9, 2026
 · 
3 min read
Press Releases
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
February 9, 2026
 · 
3 min read
Press Releases
Avacta appoints Francis Wilson as Chief Scientific Officer
February 9, 2026
 · 
4 min read
Press Releases
BioPorto A/S Appoints Chief Financial Officer
February 9, 2026
 · 
2 min read
Press Releases
Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
February 9, 2026
 · 
7 min read
Press Releases
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
February 9, 2026
 · 
8 min read
Press Releases
InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP-538 in China
February 9, 2026
 · 
2 min read
Press Releases
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
February 9, 2026
 · 
12 min read
Press Releases
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
February 9, 2026
 · 
4 min read
Press Releases
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
February 9, 2026
 · 
17 min read
Press Releases
Public Advisory - Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug
February 9, 2026
 · 
3 min read
Press Releases
Roche’s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
February 9, 2026
 · 
10 min read
Press Releases
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
February 9, 2026
 · 
10 min read
Press Releases
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
February 9, 2026
 · 
3 min read
Press Releases
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
February 9, 2026
 · 
5 min read
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 9, 2026
 · 
1 min read
Press Releases
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 9, 2026
 · 
4 min read
Press Releases
Spyre Therapeutics Announces Grants of Inducement Awards - February 6, 2026
February 9, 2026
 · 
1 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 9, 2026
 · 
2 min read
Press Releases
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 9, 2026
 · 
2 min read
Press Releases
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 9, 2026
 · 
2 min read
Press Releases
Hemex Health Receives FDA Breakthrough Device Designation for Gazelle® Hb Variant Test
February 9, 2026
 · 
2 min read
Press Releases
Pendopharm Announces the Approval of Yorvipath® (palopegteriparatide injection) for the Treatment of Chronic Hypoparathyroidism in Adults
February 9, 2026
 · 
4 min read
Press Releases
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
February 9, 2026
 · 
6 min read
Press Releases
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
February 9, 2026
 · 
3 min read
Press Releases
R1 Appoints Andy Brailo as Chief Commercial Officer
February 9, 2026
 · 
2 min read
Press Releases
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
February 8, 2026
 · 
18 min read
Press Releases
Atrandi Biosciences Brings Single-Cell Direct Multiomics Technology to SLAS 2026 Conference
February 8, 2026
 · 
3 min read
Press Releases
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
February 8, 2026
 · 
16 min read
Press Releases
CaseBioscience® Launches CaseCryo® CTG DMSO and CaseStor® HSS at ATW 2026, Advancing Next-Generation Biopreservation for Cell Therapy
February 8, 2026
 · 
4 min read
Load More